fusidic acid has been researched along with Skin Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Diffey, B | 1 |
| D'Souza, G; Evans, GRD | 1 |
| Fourtanier, A | 1 |
| Agapakis-Causse, C; Belaidi, JP; Chaubo, C; Marrot, L; Meunier, JR; Perez, P | 1 |
| Lansang, RP; Lytvyn, Y; Maliyar, K; Mufti, A; Sachdeva, M; Sibbald, RG; Yeung, J | 1 |
| Clark, L; Doyle, RS; Shroeder, S | 1 |
| Afford, R; Sladden, C | 1 |
| Ayuthaya, PK; Nakakes, A; Uaboonkul, T | 1 |
2 review(s) available for fusidic acid and Skin Neoplasms
| Article | Year |
|---|---|
Mexoryl: a review of an ultraviolet a filter.
Topics: Camphanes; Humans; Melanoma; Skin Aging; Skin Neoplasms; Sulfonic Acids; Sunburn; Sunscreening Agents; Ultraviolet Rays | 2007 |
Treatment outcomes in confluent and reticulated papillomatosis: A systematic review.
Topics: Administration, Cutaneous; Administration, Oral; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Dermatology; Emollients; Fusidic Acid; Glucocorticoids; Humans; Papilloma; Practice Guidelines as Topic; Retinoids; Skin Neoplasms; Treatment Outcome | 2021 |
1 trial(s) available for fusidic acid and Skin Neoplasms
| Article | Year |
|---|---|
A randomized control study of the prevention of hyperpigmentation post Q-switched Nd:YAG laser treatment of Hori nevus using topical fucidic acid plus betamethasone valerate cream versus fucidic acid cream.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Betamethasone; Drug Combinations; Female; Fusidic Acid; Humans; Hyperpigmentation; Lasers, Solid-State; Male; Middle Aged; Nevus of Ota; Skin Neoplasms | 2012 |
5 other study(ies) available for fusidic acid and Skin Neoplasms
| Article | Year |
|---|---|
New Sunscreens and the Precautionary Principle.
Topics: Camphanes; Cross-Cultural Comparison; Drug Approval; Europe; Humans; Neoplasms, Radiation-Induced; Phenols; Radiation Dosage; Siloxanes; Skin Neoplasms; Sulfonic Acids; Sunscreening Agents; Treatment Outcome; Triazines; Triazoles; Ultraviolet Rays; United States; United States Food and Drug Administration | 2016 |
Mexoryl SX protects against solar-simulated UVR-induced photocarcinogenesis in mice.
Topics: Animals; Camphanes; Camphor; Female; Humans; Mesylates; Mice; Skin Neoplasms; Sulfonic Acids; Sunscreening Agents; Ultraviolet Rays | 1996 |
An in vitro strategy to evaluate the phototoxicity of solar UV at the molecular and cellular level: application to photoprotection assessment.
Topics: Blotting, Western; Camphanes; Camphor; Cell Death; Cell Survival; Cells, Cultured; Dermatitis, Phototoxic; DNA, Mitochondrial; Electrophoresis; Humans; Melanocytes; Mesylates; Mitosis; Saccharomyces cerevisiae; Sensitivity and Specificity; Skin; Skin Neoplasms; Sulfonic Acids; Sunscreening Agents; Tumor Suppressor Protein p53; Ultraviolet Rays | 1998 |
Skin lesions following pregabalin administration in a cat.
Topics: Analgesics; Animals; Betamethasone; Carcinoma, Squamous Cell; Cat Diseases; Cats; Drug Eruptions; Fusidic Acid; Neuralgia; Pain, Postoperative; Pregabalin; Skin Neoplasms | 2017 |
Erosive pustular dermatosis.
Topics: Administration, Cutaneous; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Biopsy; Clobetasol; Diagnosis, Differential; Fusidic Acid; Humans; Male; Scalp Dermatoses; Skin Diseases, Vesiculobullous; Skin Neoplasms | 2019 |